Brixton Biosciences (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- May 31, 2024
- Vertical
- Life Sciences
- Funding URL
- View Funding Page
- Funding Amount:
- $33,000,000
Company Info
- Company Description
- Brixton Biosciences, a spin-out from Massachusetts General Brigham, is a clinical stage life sciences company that develops novel therapies for treating pain. Its leadership team comprises experienced managers and key medical advisors, enabling a patient-centric strategy driven by the best of the best.
- Market
- Pain Management
- Location
- Cambridge, MA, USA
- Coinvestors
- Catalyst Health Ventures, Excelestar Ventures, PV Capital Management, Schooner Capital, Sparta Group, SV Health Investors